A new study published in Viral Immunology has sparked a debate on whether the human papilloma virus (HPV) vaccination should be given to men. The review - available at http://www.liebertpub.com/vim - was conducted by Gorren Low and colleagues from University of Southern California and David Geffen School of Medicine, Los Angeles, CA, and Georgetown University School of Medicine, Washington, DC. The researchers assessed how cost effective it is to expand routine HPV vaccination to include young males as well as the potential for reducing illness caused by HPV infection...
More...
More...